Cargando…
Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections
BACKGROUND: Cytomegalovirus (CMV) infection in transplant recipients is reported to replicate with a doubling time of 1.2–2 days, and weekly screening is recommended for early diagnosis. We re-evaluated these features in our cohort of transplant recipients. METHODS: The CMV doubling time of the firs...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534685/ https://www.ncbi.nlm.nih.gov/pubmed/26288842 http://dx.doi.org/10.1016/j.ebiom.2015.05.003 |
_version_ | 1782385488858972160 |
---|---|
author | Lodding, I.P. Sengeløv, H. da Cunha-Bang, C. Iversen, M. Rasmussen, A. Gustafsson, F. Downing, J.G. Grarup, J. Kirkby, N. Frederiksen, C.M. Mocroft, A. Sørensen, S.S. Lundgren, J.D. |
author_facet | Lodding, I.P. Sengeløv, H. da Cunha-Bang, C. Iversen, M. Rasmussen, A. Gustafsson, F. Downing, J.G. Grarup, J. Kirkby, N. Frederiksen, C.M. Mocroft, A. Sørensen, S.S. Lundgren, J.D. |
author_sort | Lodding, I.P. |
collection | PubMed |
description | BACKGROUND: Cytomegalovirus (CMV) infection in transplant recipients is reported to replicate with a doubling time of 1.2–2 days, and weekly screening is recommended for early diagnosis. We re-evaluated these features in our cohort of transplant recipients. METHODS: The CMV doubling time of the first CMV infection in the first year post-transplant could be calculated for 193 recipients of haematopoietic stem cell or solid organ transplantation. Factors determining the proportion of recipients with a high diagnostic CMV viral load (≥ 18,200 IU/mL) were explored using mathematical simulation. FINDINGS: The overall median doubling time was 4.3 days (IQR 2.5–7.8) and was not influenced by prior CMV immunity, or type of transplantation (p > 0.4). Assuming a fixed doubling time of 1.3 days and screening intervals of 7 or 10 days, 11.1% and 33.3% were projected to have a high CMV viral load at diagnosis, compared to 1.4% and 4.3% if the doubling time varies as observed in our cohort. Consistently, 1.9% of recipients screened weekly had a high diagnostic virus load. INTERPRETATION: Screening intervals can be extended to 10 days in cohorts with comparable CMV doubling time, whereas shorter than 7 days is required in cohorts with shorter doubling times to maintain pre-emptive screening quality. |
format | Online Article Text |
id | pubmed-4534685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-45346852015-08-18 Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections Lodding, I.P. Sengeløv, H. da Cunha-Bang, C. Iversen, M. Rasmussen, A. Gustafsson, F. Downing, J.G. Grarup, J. Kirkby, N. Frederiksen, C.M. Mocroft, A. Sørensen, S.S. Lundgren, J.D. EBioMedicine Original Article BACKGROUND: Cytomegalovirus (CMV) infection in transplant recipients is reported to replicate with a doubling time of 1.2–2 days, and weekly screening is recommended for early diagnosis. We re-evaluated these features in our cohort of transplant recipients. METHODS: The CMV doubling time of the first CMV infection in the first year post-transplant could be calculated for 193 recipients of haematopoietic stem cell or solid organ transplantation. Factors determining the proportion of recipients with a high diagnostic CMV viral load (≥ 18,200 IU/mL) were explored using mathematical simulation. FINDINGS: The overall median doubling time was 4.3 days (IQR 2.5–7.8) and was not influenced by prior CMV immunity, or type of transplantation (p > 0.4). Assuming a fixed doubling time of 1.3 days and screening intervals of 7 or 10 days, 11.1% and 33.3% were projected to have a high CMV viral load at diagnosis, compared to 1.4% and 4.3% if the doubling time varies as observed in our cohort. Consistently, 1.9% of recipients screened weekly had a high diagnostic virus load. INTERPRETATION: Screening intervals can be extended to 10 days in cohorts with comparable CMV doubling time, whereas shorter than 7 days is required in cohorts with shorter doubling times to maintain pre-emptive screening quality. Elsevier 2015-05-08 /pmc/articles/PMC4534685/ /pubmed/26288842 http://dx.doi.org/10.1016/j.ebiom.2015.05.003 Text en © 2015 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Lodding, I.P. Sengeløv, H. da Cunha-Bang, C. Iversen, M. Rasmussen, A. Gustafsson, F. Downing, J.G. Grarup, J. Kirkby, N. Frederiksen, C.M. Mocroft, A. Sørensen, S.S. Lundgren, J.D. Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections |
title | Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections |
title_full | Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections |
title_fullStr | Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections |
title_full_unstemmed | Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections |
title_short | Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections |
title_sort | clinical application of variation in replication kinetics during episodes of post-transplant cytomegalovirus infections |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534685/ https://www.ncbi.nlm.nih.gov/pubmed/26288842 http://dx.doi.org/10.1016/j.ebiom.2015.05.003 |
work_keys_str_mv | AT loddingip clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT sengeløvh clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT dacunhabangc clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT iversenm clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT rasmussena clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT gustafssonf clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT downingjg clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT grarupj clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT kirkbyn clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT frederiksencm clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT mocrofta clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT sørensenss clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT lundgrenjd clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections AT clinicalapplicationofvariationinreplicationkineticsduringepisodesofposttransplantcytomegalovirusinfections |